{"nct_id":"NCT00299871","title":"Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","status_verified_date":"2014-01","start_date":"2006-02","start_date_type":null,"primary_completion_date":"2007-08","primary_completion_date_type":"ACTUAL","completion_date":"2007-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}